Coverage
-
February 19, 2014
A U.S. Securities and Exchange Commission case alleging two men traded on inside information supplied by Hunton & Williams LLP drug patent attorney Robert Schulman has spurred a criminal investigation, federal prosecutors revealed Tuesday.
4 other articles on this case.
View all »